News about Global Pharma

FDA-Approved Wegovy Now Easier to Access via Novo Nordisk's New Telehealth Initiative

In March 2025, Novo Nordisk launched NovoCare® Pharmacy to provide direct-to-patient, convenient home shipments of all dose strengths of Wegovy® at a reduced cost.

Global Pharma | 30/04/2025 | By Abha |  500

Zydus Secures Final Approval from USFDA for Niacin Extended-Release Tablets

Zydus Lifesciences has received final USFDA approval to manufacture Niacin Extended-Release Tablets in 500 mg, 750 mg, and 1,000 mg dosage, targeting cholesterol management and cardiovascular risk reduction.

Global Pharma | 30/04/2025 | By Abha |  524

Transneural Therapeutics Appoints Dr. Mark Demitrack as Chief Research and Development Officer

Dr. Demitrack is an accomplished, internationally recognised neuropsychiatrist with deep expertise in innovative clinical research and strategic business planning.

Global Pharma | 30/04/2025 | By Abha |  399

Navamedic Extends Imdur Distribution Agreement Until 2032

Imdur® (isosorbide mononitrate), is a prescription medication used to prevent angina pectoris due to heart disease.

Global Pharma | 30/04/2025 | By Abha |  536

PredxBio and Hamamatsu Partner to Advance Spatial Biology for Cancer Research

PredxBio, an AI-driven spatial biomarker discovery company, has entered into a strategic collaboration with Hamamatsu Photonics to combine advanced imaging and analytics technologies for accelerating cancer research and immuno-oncology discoveries.

Global Pharma | 29/04/2025 | By Manvi |  256

Nipro India Unveils Glass Cartridge Expansion at Pune Plant

The Nipro Pune plant is an experienced manufacturing site that has been producing premium-quality glass containers for leading Indian and global pharmaceutical companies for years.

Global Pharma | 29/04/2025 | By Abha |  560

Morepen to Expand Portfolio with Launch of Resmetirom for Fatty Liver Disease

Morepen Laboratories Ltd. has received approval from the Subject Expert Committee (SEC) of the CDSCO to initiate Bioequivalence studies for Resmetirom, a promising new therapy for non-alcoholic steatohepatitis (NASH), marking a key step in its expansion into the hepatology segment.

Global Pharma | 29/04/2025 | By Manvi |  444

Healthy.io Signs Agreement to Acquire Labrador Health

This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone.

Global Pharma | 29/04/2025 | By Manvi |  183

GammaPod Breast Cancer Treatment Debuts in Europe with Tema Sinergie

GammaPod, one of the most advanced innovations in the treatment of breast cancer, officially arrives in Europe thanks to the commitment of Tema Sinergie SpA, an Italian company based in Faenza.

Global Pharma | 29/04/2025 | By Manvi |  194

Biocon Biologics Gets Positive CHMP Opinions for Biosimilar Denosumab in Europe

Biocon Biologics has received positive CHMP opinions recommending approval of its denosumab biosimilars, Vevzuo and Denosumab BBL, for bone health indications in Europe.

Global Pharma | 28/04/2025 | By Manvi |  223